GlassScriptPhysician profile
Laura Moore
NPI 1134786114
$1,089.32
in general payments reported to CMS, 2019-2025
17 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $273 · 2023: $354 · 2024: $89.63 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $146.99 | 2021-2023 | |
| Novo Nordisk INC | $142.46 | 2025 | Wegovy |
| Amgen INC. | $134.29 | 2023-2024 | Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $100.85 | 2022-2023 | |
| Gilead Sciences, INC. | $95.49 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.95 | 2022-2023 | |
| Abbvie INC. | $76.45 | 2021-2023 | |
| Inari Medical, INC. | $54.58 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Supernus Pharmaceuticals, INC. | $49.23 | 2021-2022 | |
| Lilly USA, LLC | $42.92 | 2022-2023 | Mounjaro |
| Averitas Pharma INC. | $41.35 | 2025 | Qutenza |
| Antares Pharma, INC. | $23.73 | 2022 | |
| Impel Pharmaceuticals LLC | $22.74 | 2025 | Trudhesa |
| Boston Scientific Corporation | $19.48 | 2023 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.45 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.66 | 2023 | Cologuard Collection Kit |
| Biogen, INC. | $13.70 | 2023 | Vumerity, Tysabri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.